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Abstract Core binding factors (CBFs) play key roles in several
developmental pathways and in human disease. CBFs consist of a
DNA binding CBFK subunit and a non-DNA binding CBFL
subunit that increases the affinity of CBFK for DNA. We
performed sedimentation equilibrium analyses to unequivocally
establish the stoichiometry of the CBFK:L:DNA complex.
Dissociation constants for all four equilibria involving the CBFK
Runt domain, CBFL, and DNA were defined. Conformational
changes associated with interactions between CBFK, CBFL, and
DNA were monitored by nuclear magnetic resonance and
circular dichroism spectroscopy. The data suggest that CBFL
‘locks in’ a high affinity DNA binding conformation of the CBFK
Runt domain.
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1. Introduction
Core binding factors (CBFs, also known as PEBP2) are
heterodimeric transcription factors consisting of a DNA bind-
ing subunit (CBFK) and a non-DNA binding CBFL subunit
[1^4]. CBFK subunits are encoded by three genes in mammals,
Runx1, Runx2, and Runx3 (formerly called Cbfa2, Cbfa1, and
Cbfa3, also known as Pebpa2b, Pebpa2a, and Pebpa2c, or
AML1, AML3, and AML2, respectively) [3,5^8]. CBFL is en-
coded by one gene, Cbfb (or Pebpb2) [2,4]. Homozygous dis-
ruption of either the Runx1 or Cbfb gene results in identical
defects, including embryonic lethality from extensive hemor-
rhaging in the central nervous system and a severe block at
the fetal liver stage of hematopoiesis [9^13]. The Runx2 gene
is required for bone formation [14,15], while the in vivo func-
tion of Runx3 is unknown. Mutations in the one copy of the
RUNX2 (CBFA1) gene cause cleidocranial dysplasia, an in-
herited skeletal abnormality [16]. Haploinsu⁄ciency of
RUNX1 causes a familial platelet disorder with predisposition
for acute myeloid leukemia [17]. A large proportion of acute
leukemias and a smaller number of therapy-related leukemias
are associated with chromosomal translocations involving the
RUNX1 and CBFB genes [18], or point mutations in one or
both copies of the RUNX1 gene [17,19].
The Runt domain of the CBFK subunits both binds DNA
and heterodimerizes with the CBFL subunit [3,20]. The Runt
domain alone can bind DNA in vitro, but its a⁄nity for DNA
increases in the presence of CBFL. CBFL does not appear to
establish contacts with additional phosphates or purine bases
in the DNA [1,4], therefore it was proposed that CBFL sta-
bilizes a conformation of CBFK that is favorable for DNA
binding [4,21]. Here we provide experimental support for this
hypothesis.
2. Materials and methods
2.1. Protein and DNA preparation
The full length CBFL(187) protein, the CBFL heterodimerization
domain [CBFL(141)], and an amino acid 41^214 Runt domain frag-
ment from Runx1 (AML1, hereafter referred to as CBFK) were ex-
pressed and puri¢ed as described previously [22^24]. Two complemen-
tary strands of a high a⁄nity CBF binding site [25] were synthesized
and puri¢ed via anion exchange chromatography (Midland Certi¢ed
Reagent Company). Annealed double-stranded oligonucleotides were
separated from single-stranded material by chromatography on Q-
Sepharose. The ¢nal puri¢ed DNA was exchanged into the appropri-
ate bu¡er by lyophilization and size exclusion chromatography on
Sephadex G25.
2.2. Sedimentation equilibrium
Complexes of the Runx1 Runt domain (CBFK), CBFL, and DNA
were prepared by combining appropriate quantities of dialyzed pro-
tein and/or DNA to obtain ¢nal complex concentrations of 31 WM.
High speed sedimentation equilibrium experiments [26] were con-
ducted at 20‡C in a Beckman XL-1 ultracentrifuge at rotor speeds
of 20 000, 25 000, 30 000, and 40 000 rpm using interference detection.
Three cell loading concentrations were examined (15^3.75 WM) in
20 mM potassium phosphate (pH 7.5), 25 mM KCl, 0.5 mM dithio-
threitol (DTT). Data were ¢t using NONLIN [27]. The solvent density
(1.002 g/ml), Runt domain monomer molecular weight (19 112 g/mol),
formal charge (+8.5) and partial speci¢c volume (0.7341 ml/g), as well
as the CBFL monomer molecular weight (22 103 g/mol), formal
charge (35) and partial speci¢c volume (0.7161) were calculated
using the program Sednterp [28]. The expected molecular weight
(41 215 g/mol) and partial speci¢c volume (0.7244) of the CBFK :L
complex were calculated from these subunit values. For the 18 bp
DNA, a composition (9 A, 9 T, 9 C and 9 G) molecular weight of
11 547 g/mol is calculated. Ordinarily, a partial speci¢c volume of
0.54 ml/g is assumed for long duplex DNA in physiological solvents
[29]. However, for a DNA oligonucleotide bound to a protein, the
partial speci¢c volume is di⁄cult to estimate. Assuming 0.54 ml/g for
the DNA, partial speci¢c volumes of 0.6763 ml/g and 0.6939 ml/g
were calculated for the CBFK :DNA and CBFK :L :DNA complexes
respectively, and an additional uncertainty of 0.01 ml/g in the partial
speci¢c volumes was included when calculating molecular weights for
these two complexes.
2.3. Dissociation constant measurements
The core site from the SL3-3 murine leukemia virus enhancer was
used to measure binding of CBFK to DNA in the presence or absence
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of CBFL(187). Equilibrium binding constants of CBFK for DNA, and
CBFL(187) for a CBFK :DNA complex were measured by electropho-
retic mobility shift assay (EMSA), and analyzed as described previ-
ously [22,23]. The a⁄nity of CBFK :L for DNA was determined by
titrating CBFK onto a ¢xed amount of DNA (2U10313 M) in the
presence of 5 WM CBFL(187).
2.4. Isothermal titration calorimetry
The equilibrium binding constant for the formation of a CBFK :L
complex was determined by isothermal titration calorimetry (ITC).
All measurements were carried out at 10‡C on a MicroCalorimetry
System MCS ITC (MicroCal Inc.). A solution of 47.5 WM CBFK was
titrated with aliquots of 595 WM CBFL(141)(A137S). Ligand dilution
enthalpies were subtracted from the titration, and data were ¢tted to a
one-site model using Origin (MicroCal Inc.).
2.5. Circular dichroism (CD) spectroscopy
CD experiments were performed at 20‡C on a Jasco 715 spectrom-
eter calibrated using 10-camphorsulfonic acid. The experiments were
performed with a 1.0 nm band width, and data points taken every 0.5
nm with an 8 s averaging time. Measurements in the far UV (205^325
nm) of binary and ternary complexes were performed using a Hellma
quartz mixing cuvette. A non-interacting CD spectrum was measured
by averaging four scans. The mixing cell was then inverted several
times, allowing samples from the two chambers to £ow into the mix-
ing cavity, and the complexed or interacting CD spectrum recorded
also with four scans. The concentration of all protein and DNA
components was 2.5 WM in 20 mM potassium phosphate (pH 7.5),
25 mM potassium chloride, and 0.5 mM DTT. The ellipticity values
for the bu¡er were subtracted from the experimental values obtained
for uncomplexed and complexed protein^DNA samples. No smooth-
ing of the data was applied at any stage.
2.6. NMR spectroscopy
The ternary CBFK :L :DNA complex was prepared by adding unla-
beled CBFL(141) to a sample of 100% 2H,13C,15N-labeled Runx1
Runt domain complexed to unlabeled DNA [24]. TROSY-based
HNCA, HN(CA)CB, HNCO, and 15N-edited NOESY spectra [30]
were recorded under the conditions used for backbone assignment
previously [24]. 15N amino acid speci¢cally labeled samples of the
Runt domain [24] were also titrated with unlabeled CBFL(141) and
2D TROSY spectra recorded to assist in the resonance assignments.
All experiments were carried out on a 600 MHz Varian Innova spec-
trometer equipped with a Nalorac triple resonance gradient probe.
Table 1
Results of sedimentation equilibrium analyses of CBFK Runt domain complexes: global ¢ts of data for a single ideal species model
Sample Mz (g/mol)a RMSb Expected MW
CBFK :DNA 26 500 (25 400^27 740) 0.017 30 660
CBFK :L 41 003 (40 984^41 022) 0.015 41 220
CBFK :L :DNA 46 290 (43 760^49 000) 0.031 52 760
az-average molecular weight calculated from NONLIN values, calculated assuming a partial speci¢c volume of 0.54 ml/g for the DNA.
bRoot mean square of the variance of ¢t.
Fig. 1. Equilibrium DNA binding studies of CBFK, CBFL, and DNA. Data are presented as the mean (+S.D.) of three independent experi-
ments. A: Determination of K2 describing binding of the CBFK Runt domain to DNA. B: Determination of K3 describing the interaction of
CBFL with CBFK :DNA. C: Determination of K4 describing the binding of CBFK :L to DNA. D: Schematic representation of the conforma-
tional changes occurring in CBFK, CBFL, and DNA. The calculated (K1) equilibrium dissociation constant is indicated.
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The resulting 15N and NH assignments were compared to those ob-
tained previously for the binary Runt domain^DNA complex [24].
A ternary complex containing 100% 2H,13C,15N-labeled CBFL(141)
was prepared by addition of unlabeled CBFK :DNA complex to the
labeled CBFL(141). TROSY-based HNCA, HN(CA)CB, HNCO, and
15N-edited NOESY spectra [30] were recorded as above to obtain
complete backbone resonance assignments. Chemical shifts for un-
complexed CBFL(141) were taken from Huang et al. [31].
3. Results and discussion
3.1. Stoichiometry
The stoichiometries of the CBFK :L, CBFK :DNA and
CBFK :L :DNA complexes were established by sedimentation
equilibrium (Table 1). All complexes sedimented as single
ideal components with molecular weights consistent with 1:1
(CBFK :L and CBFK :DNA) or 1:1:1 (CBFK :L :DNA) com-
plexes. The measured molecular weight of CBFK :L is within
0.6% of the predicted value. While the molecular weights cal-
culated for the two protein^DNA complexes are consistent
with the expected stoichiometries, the molecular weights are
almost 15% lower than anticipated. These lower molecular
weights are not a consequence of dissociation, since there is
no systematic decrease in the molecular weights with decreas-
ing concentration. Likewise, there is no systematic increase in
molecular weight with decreasing concentration, indicating
Fig. 2. Isothermal calorimetric titration of CBFK with
CBFL(141)(A137S). Top: Raw data from the addition of 10 Wl ali-
quots of 595 WM CBFL(141)(A137S) to 47.5 WM Runx1(41^214)
(CBFK). Bottom: Results from the least squares ¢t to a one binding
site model of the heat exchanged per mol of CBFL(141)(A137S) ver-
sus the molar ratio of CBFL(141)(A137S) to CBFK. Numerical val-
ues for the stoichiometry (N), equilibrium dissociation constant
(K1), and the molar change in enthalpy (H) are given in the box.
C
Fig. 3. Conformational changes in the CBF subunits and DNA monitored by far UV circular dichroism. In all cases dotted lines represent un-
mixed spectra, and solid lines represent mixed (complexed) spectra.
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that the lower molecular weight is not a consequence of sam-
ple heterogeneity or thermodynamic non-ideality [26,27].
These observations suggest that the partial speci¢c volume
of the complexes is about 0.04 ml/g larger than calculated
assuming a partial speci¢c volume of 0.54 ml/g for the
DNA. An increased partial speci¢c volume for the DNA
would be expected if complex formation reduces its net charge
and alters the counterion binding signi¢cantly.
3.2. Measurement of dissociation constants
We carried out a detailed analysis of the binding constants
describing the interactions between CBFK, CBFL, and DNA
by EMSA (Fig. 1). K2 is the dissociation constant for CBFK
binding to DNA (Fig. 1A). K3 describes the binding of CBFL
to the CBFK :DNA complex (Fig. 1B). K4 represents binding
of the CBFK :L heterodimer to DNA (Fig. 1C). The measured
dissociation constants allow us to calculate the value of K1
describing the interaction between CBFK and CBFL o¡ DNA
from the equation K2K3 = K1K4 (Fig. 1D). Comparison of the
dissociation constants K2 and K4 and their errors shows that
CBFL causes a statistically signi¢cant six-fold enhancement in
DNA binding by the CBFK Runt domain. The observed
change in the Kd values corresponds to a vvG of 1 kcal/mol
associated with the binding of CBFK to DNA in the absence
and presence of CBFL.
We also measured K1 directly by ITC to con¢rm the K1
value calculated from EMSAs (Fig. 2). Attempts to obtain
calorimetric data with CBFL(141) yielded very small enthal-
pies and therefore poor quality data. In contrast, an A137CS
mutant of CBFL(141) yielded larger enthalpies and corre-
spondingly better data. NMR data collected on
CBFL(141)(A137S) showed only minor perturbations relative
Fig. 4. NMR chemical shift perturbation mapping of the CBFK :L interaction. A: NH chemical shift changes in CBFK upon binding of CBFL.
The Runt domain is numbered relative to the AML1 protein [5]. 15N shifts are in green and HN shifts are in red. B: CK chemical shift changes
in the Runx1 Runt domain (CBFK) upon binding of CBFL. C: NH chemical shift changes in CBFL upon binding of CBFK :DNA. 15N shifts
are in green and HN shifts are in red. D: CK chemical shift changes in CBFL upon binding of CBFK :DNA.
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to CBFL(141) which were isolated to the immediate vicinity of
the mutation (not shown), thus the mutant protein retains the
same fold as CBFL(141). In addition, the C-terminal region of
the last helix in CBFL(141) where A137 is located is not in-
volved in contacts with CBFK [31]. The value of K1 obtained
from calorimetry using CBFL(141)(A137S) was 0.15 WM, in
excellent agreement with the 0.11 WM value obtained indi-
rectly from the EMSA measurements for the full length
CBFL.
3.3. CD spectroscopy
We employed a two-chambered mixing cell to record un-
mixed and mixed CD spectra associated with all the equilibria
illustrated in Fig. 1. In Fig. 3A, the ‘unmixed’ spectrum rep-
resents the combined spectra of the isolated CBFK Runt do-
main and DNA in solution, while the ‘mixed’ spectrum cor-
responds to that of the CBFK :DNA complex. An increase in
ellipticity at 275 nm and the very slight decrease at 250 nm
suggest the DNA conformation changes upon CBFK binding.
The changes observed at 275 nm are indicative of helix un-
winding, in agreement with other results showing DNA is
bent upon CBFK binding [32]. Unambiguous assignment of
changes in the Runt domain conformation is not possible due
to spectral overlap of protein and DNA in the 205^225 nm
region.
Mixing experiments with CBFK and CBFL document a
substantial change in the 205^225 nm region of the spectrum
(Fig. 3B), indicating that a signi¢cant conformational change
occurs in one or both proteins upon heterodimerization. Bind-
ing of the preformed CBFK :L complex to DNA is accompa-
nied by changes in the DNA region of the spectrum (230^
275 nm) (Fig. 3C), closely resembling those induced by
CBFK alone (Fig. 3A). Finally, when the pre-formed
CBFK :DNA complex is mixed with CBFL (Fig. 3D) there is
a substantial change in the 205^225 nm region of the spectrum
resembling that seen upon heterodimerization in solution (Fig.
3B), whereas the change in the DNA region of the spectrum
(230^275 nm) is minor. In summary, the CD data indicate
that heterodimerization of CBFK and CBFL either in solution
or on the DNA is accompanied by signi¢cant conformational
changes in one or both proteins. CBFK by itself induces a
conformational change in the DNA that is not signi¢cantly
in£uenced by addition of the CBFL subunit.
3.4. NMR spectroscopy
We added CBFL(141) to 2H,13C,15N-labeled Runt domain
bound to unlabeled DNA, and assigned the backbone chem-
ical shifts for the Runt domain. Comparison with the back-
bone chemical shifts of the Runt domain:DNA complex [24]
provides a map of the CBFL binding site (Fig. 4A). Substan-
tial NH chemical shift perturbations (s 2.0 ppm) in the Runt
domain upon CBFL binding were identi¢ed for 17 residues:
66, 67, 107, 110, 111, 113^115, 148, 149, 159^163, 165^166.
Residue 164 was not assigned in the Runt domain:DNA com-
plex [24], so no comparison data are available for this residue.
Fig. 5 displays these residues on a ribbon representation of the
Runt domain structure [24]. The highly perturbed residues
map to one face of the protein, and clearly identify the surface
utilized on the Runt domain for CBFL binding. The general
location of the CBFL binding site is in agreement with anoth-
er chemical shift perturbation study of this system [21], how-
ever the magnitude and locations of the observed changes
di¡er. The dramatic changes observed between residues 159
and 166 were not reported previously because not all residues
in this region were assigned [21]. Assignments for residues in
this region and in the neighboring L-strand of the protein
proved di⁄cult to obtain because of apparent exchange
broadening that degraded the quality of the triple resonance
data. The quality of the triple resonance data in this region of
the Runt domain in the ternary complex with CBFL and
DNA is substantially improved, and the exchange broadening
seen in the binary Runt domain:DNA complex is apparently
quenched (data not shown). This behavior is consistent with a
model in which the Runt domain exchanges between two or
more conformations in this region of the protein. Upon CBFL
binding, one conformation becomes locked in.
CK chemical shifts are relatively insensitive to contact-in-
duced shifts, but are very sensitive indicators of the backbone
dihedral angles [33], and thus provide a clear indicator of
changes in backbone conformation, i.e. conformational
changes. Fig. 4B shows the changes in the CK chemical shifts
in the Runt domain upon CBFL binding. For comparison, the
same data for CBFL are given in Fig. 4D. The CK chemical
shift changes in the 159^166 region of the Runt domain are
Fig. 5. Map of observed chemical shift changes from Fig. 4A on a
ribbon diagram of the Runt domain. The L-strand regions are col-
ored red. Loop regions, all of which have been implicated in close
contacts with the DNA, are colored blue. Residues showing large
perturbations upon CBFL binding as described in the text are col-
ored green.
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signi¢cantly more dramatic than CK chemical shift changes
seen in CBFL or in any other region of the Runt domain
structure. The substantial nature of these changes strongly
indicates that there is a conformational change in the Runt
domain in this region upon CBFL binding. As we have iden-
ti¢ed protein^DNA NOEs for residues just C-terminal to this
region as well as in spatially proximal loops [24], perturba-
tions here are very likely to alter the protein^DNA interface,
and provide a rationale for the ability of CBFL to increase the
a⁄nity of CBFK for DNA.
3.5. Conclusions
We have presented evidence from a variety of biophysical
methods that CBFL induces a localized conformational
change in the CBFK (Runx1) Runt domain that increases
the a⁄nity of the Runt domain for DNA. The proximity of
this site to residues known to be in contact with the DNA is
consistent with this conformational change altering the pro-
tein^DNA interface in some manner. De¢nitive proof of this
conformational change awaits detailed structural studies of
these complexes, however the data presented strongly support
such a model.
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